Cargando…

Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003

PURPOSE: We hypothesized that bevacizumab will potentiate activity of pembrolizumab. We conducted a phase Ib/II, single-arm, multisite clinical trial of the combination in metastatic renal cell carcinoma (RCC). PATIENTS AND METHODS: Patients with metastatic clear cell RCC who experienced progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dudek, Arkadiusz Z., Liu, Li C., Gupta, Shilpa, Logan, Theodore F., Singer, Eric A., Joshi, Monika, Zakharia, Yousef N., Lang, Joshua M., Schwarz, James K., Al-Janadi, Anas, Alva, Ajjai S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145584/ https://www.ncbi.nlm.nih.gov/pubmed/32097091 http://dx.doi.org/10.1200/JCO.19.02394

Ejemplares similares

Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
por: Joshi, Monika, et al.
Publicado: (2023)

Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
por: Nguyen, Charles B., et al.
Publicado: (2022)

Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases
por: Phadke, Sneha D., et al.
Publicado: (2016)

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
por: Finn, Richard S., et al.
Publicado: (2020)

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma
por: Atkins, Michael B, et al.
Publicado: (2015)

The “GU-GU-RU” project to eliminate discrimination related to the health effects of the Fukushima nuclear accident
por: Amir, Isamu, et al.
Publicado: (2023)

Network Pharmacological Analysis and Animal Experimental Study on Osteoporosis Treatment with GuBen-ZengGu Granules
por: Wang, Kai, et al.
Publicado: (2023)

Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors
por: Rahma, Osama E, et al.
Publicado: (2022)

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma
por: Silk, Ann W., et al.
Publicado: (2023)

An Euler system for GU(2, 1)
por: Loeffler, David, et al.
Publicado: (2021)

Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
por: Ellingsen, Espen B., et al.
Publicado: (2023)

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer
por: Zhang, Tian, et al.
Publicado: (2020)

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
por: Weiss, Glen J, et al.
Publicado: (2017)

Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy
por: Venur, Vyshak Alva, et al.
Publicado: (2017)

Real-World Therapy Management and Outcomes of First-Line Axitinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma in the United States
por: Zakharia, Yousef, et al.
Publicado: (2022)

Current standards and practice changing studies in genitourinary (GU) cancers—a review of studies in localized/early GU cancers
por: Tan, W.C., et al.
Publicado: (2022)

Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report
por: Webb, Mason J, et al.
Publicado: (2023)

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
por: Waks, Adrienne G, et al.
Publicado: (2022)

Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
por: Park, H., et al.
Publicado: (2022)

Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
por: Amin, Asim, et al.
Publicado: (2015)

Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report
por: Liu, Mei, et al.
Publicado: (2022)

Top Physics at ATLAS 003
por: Stavropoulos, G D
Publicado: (2004)

A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer
por: Fong, Lawrence, et al.
Publicado: (2021)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2021)

The electrostatic characteristics of G·U wobble base pairs
por: Xu, Darui, et al.
Publicado: (2007)

GU Evaluation and Management of Renal Transplant Candidates and Recipients
por: Bretan, Peter N.
Publicado: (2004)

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
por: Al-Amri, Abdulrahman Mohammed, et al.
Publicado: (2017)

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)()()()
por: Si, Lu, et al.
Publicado: (2019)

Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study
por: Taniguchi, Hiroya, et al.
Publicado: (2023)

An audit of Colposcopy referrals from a GU/STD clinic
por: O'Connor, Catherine, et al.
Publicado: (2008)

Estimation of the cutoff value of vitamin D: the Dong-gu study
por: Choi, Seong-Woo, et al.
Publicado: (2015)

Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report
por: Liu, Yanxin, et al.
Publicado: (2023)

Pembrolizumab reactivates pulmonary granulomatosis
por: Al-dliw, Majdi, et al.
Publicado: (2017)

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
por: Chow, Laura Q.M., et al.
Publicado: (2016)

Comme une piq{circ}ure de gu{circ}epe
por: Diabaté, Massa M.
Publicado: (1985)

Frequent GU wobble pairings reduce translation efficiency in Plasmodium falciparum
por: Chan, Sherwin, et al.
Publicado: (2017)

GuPPy, a Python toolbox for the analysis of fiber photometry data
por: Sherathiya, Venus N., et al.
Publicado: (2021)

Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases
por: Yang, Gang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tshcomuk88ga5i4769ogld0376